345 related articles for article (PubMed ID: 25528484)
1. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit.
Cornejo-Juárez P; Vilar-Compte D; Pérez-Jiménez C; Ñamendys-Silva SA; Sandoval-Hernández S; Volkow-Fernández P
Int J Infect Dis; 2015 Feb; 31():31-4. PubMed ID: 25528484
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients.
Cornejo-Juárez P; Vilar-Compte D; García-Horton A; López-Velázquez M; Ñamendys-Silva S; Volkow-Fernández P
BMC Infect Dis; 2016 Jun; 16():274. PubMed ID: 27286681
[TBL] [Abstract][Full Text] [Related]
3. Analysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in China.
Wang M; Wei H; Zhao Y; Shang L; Di L; Lyu C; Liu J
Bosn J Basic Med Sci; 2019 Feb; 19(1):86-93. PubMed ID: 30579325
[TBL] [Abstract][Full Text] [Related]
4. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
Huang X; Li G; Yi L; Li M; Wang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
[TBL] [Abstract][Full Text] [Related]
5. Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes.
Mitharwal SM; Yaddanapudi S; Bhardwaj N; Gautam V; Biswal M; Yaddanapudi L
Am J Infect Control; 2016 Jul; 44(7):e113-7. PubMed ID: 26944004
[TBL] [Abstract][Full Text] [Related]
6. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study.
Nseir S; Di Pompeo C; Diarra M; Brisson H; Tissier S; Boulo M; Durocher A
Crit Care Med; 2007 May; 35(5):1318-23. PubMed ID: 17414081
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological surveillance for multidrug-resistant microorganisms in a general ICU].
Fernández-Verdugo A; Fernández J; Escudero D; Cofiño L; Forcelledo L; Telenti M; García-Prieto E; Rodríguez-García R; Álvarez-García L; Pérez-García A; Rodríguez-Lucas C; Vazquez F
Rev Esp Quimioter; 2017 Jun; 30(3):201-206. PubMed ID: 28422471
[TBL] [Abstract][Full Text] [Related]
8. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
9. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.
Daniels TL; Deppen S; Arbogast PG; Griffin MR; Schaffner W; Talbot TR
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1080-3. PubMed ID: 18837670
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study.
Agaba P; Tumukunde J; Tindimwebwa JVB; Kwizera A
BMC Res Notes; 2017 Jul; 10(1):349. PubMed ID: 28754148
[TBL] [Abstract][Full Text] [Related]
11. [Health care associated multidrug-resistant bacteria in a pediatric hospital: five year experience].
Mação P; Lopes JC; Oliveira H; Oliveira G; Rodrigues F
Acta Med Port; 2013; 26(4):385-91. PubMed ID: 24016648
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013).
Jia XQ; Pang F; Chen JZ; Jiang LX
Pathol Biol (Paris); 2015 Feb; 63(1):21-3. PubMed ID: 25553645
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
Pradhan NP; Bhat SM; Ghadage DP
J Assoc Physicians India; 2014 Oct; 62(10):18-21. PubMed ID: 25906516
[TBL] [Abstract][Full Text] [Related]
15. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
Nseir S; Blazejewski C; Lubret R; Wallet F; Courcol R; Durocher A
Clin Microbiol Infect; 2011 Aug; 17(8):1201-8. PubMed ID: 21054665
[TBL] [Abstract][Full Text] [Related]
16. Health care-associated infections in pre-transplant liver intensive care unit: Perspectives and challenges.
Hassan EA; Elsherbiny NM; Abd El-Rehim AS; Soliman AMA; Ahmed AO
J Infect Public Health; 2018; 11(3):398-404. PubMed ID: 28965794
[TBL] [Abstract][Full Text] [Related]
17. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
[TBL] [Abstract][Full Text] [Related]
18. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
[TBL] [Abstract][Full Text] [Related]
19. Healthcare-Associated Infections in Pediatric and Neonatal Intensive Care Units: Impact of Underlying Risk Factors and Antimicrobial Resistance on 30-Day Case-Fatality in Italy and Brazil.
Folgori L; Bernaschi P; Piga S; Carletti M; Cunha FP; Lara PH; de Castro Peixoto NC; Alves Guimarães BG; Sharland M; Araujo da Silva AR; Ciofi Degli Atti M
Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1302-1309. PubMed ID: 27511591
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
